Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Myth-buster

Low folate linked to 2.2x higher risk of febrile neutropenia in children with cancer — but the same study found improvements in overall survival.

This meta-analysis adds a cautionary wrinkle to the picture, but it's among the first on this specific pairing, so the surprising finding that low folate is harmful for some outcomes and beneficial for others is far from settled — especially since it can't tell us whether correcting a deficiency would flip the associations.

In children and young people undergoing cancer treatment, low blood levels of folate were strongly tied to a higher risk of febrile neutropenia — a serious treatment complication involving fever and low white blood cell counts — with a 2.2-fold increase. However, the same analysis found that low folate was also linked to better overall survival, meaning the relationship is complex and context-dependent, not a simple 'low is bad' story.

Where this fits in the evidence

This is among the first studies we've indexed on Vitamin B9 for Reduced Febrile Neutropenia Risk — treat it as an early signal until more research accumulates.

This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.

Back to top